CareTrust REIT, Inc. is a self-administered, publicly traded REIT engaged in the ownership, acquisition, financing, development and leasing of skilled nursing, senior housing and other healthcare-related properties. As of December 31, 2025, CareTrust REIT owned, directly or indirectly in consolidated joint ventures, and leased to independent operators, 407 skilled nursing facilities (each, a SNF), senior housing communities and other properties consisting of 37,628 operational beds and units located in 32 states and the United Kingdom, with the highest concentration of properties by rental income located in California, the U.K., Texas, and Tennessee. As of December 31, 2025, we also had other real estate related investments consisting of four preferred equity investments, 16 real estate secured loans receivable and five mezzanine loans receivable with a carrying value of 899.3 million US dollars and one financing receivable with a carrying value of 92.2 million US dollars. CareTrust REIT, Inc. was established and incorporated on October 29, 2013 in Maryland, USA
Financial Resilience | CareTrust REIT showcases robust financial health with impressive revenue growth, strong profit margins, and a solid balance sheet, positioning it for sustained growth |
Acquisition Prowess | Explore CareTrust's strategic acquisition pipeline and its impact on FFO growth projections, highlighting the company's aggressive expansion in the healthcare real estate secto |
Market Valuation | With a 31% YTD stock price increase, CareTrust trades at a premium. Analysts offer diverse perspectives, with price targets ranging from $31 to $34 |
Tenant Concentration | Delve into the potential risks associated with CareTrust's reliance on key tenants, particularly PACS, and how it may affect future growth strategies and market perception |
Metrics to compare | CTRE | Sector Sector - Average of metrics from a broad group of related Real Estate sector companies | Relationship RelationshipCTREPeersSector | |
|---|---|---|---|---|
P/E Ratio | 26.0x | 50.7x | 9.2x | |
PEG Ratio | 0.28 | 0.42 | 0.01 | |
Price/Book | 2.1x | 2.6x | 0.9x | |
Price / LTM Sales | 17.5x | 9.1x | 3.9x | |
Upside (Analyst Target) | 13.4% | 4.9% | 15.8% | |
Fair Value Upside | Unlock | −12.4% | 1.4% | Unlock |